BPI25-019: Empirical Study to Estimate Real World Impact of Delay in EGFR Testing on Healthcare Resource Utilization and Cost Burden Among Early-Stage NSCLC Patients
"BPI25-019: Empirical Study to Estimate Real World Impact of Delay in EGFR Testing on Healthcare Resource Utilization and Cost Burden Among Early-Stage NSCLC Patients" published on 28 Mar 2025 by National Comprehensive Cancer Network.
Authors
- Daniel Young (ORCID: https://orcid.org/0000-0001-7908-4849)
- Diganta Chowdhury
- Angela Sünder (ORCID: https://orcid.org/0000-0002-7950-8995)
- Arindam Paul (ORCID: https://orcid.org/0000-0001-8884-5881)
- Tianyuan Hu (ORCID: https://orcid.org/0000-0002-8145-5802)
- Atharv Sharma
Institutions
- AstraZeneca (United States) (US)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-03-28
- DOI
- https://doi.org/10.6004/jnccn.2024.7145
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00